Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-004383
Filing Date
2019-03-11
Accepted
2019-03-11 10:59:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28920
2 filename2.txt TEXT-EXTRACT 2846
  Complete submission text file 0000000000-19-004383.txt   43355
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filed for) CIK: 0001652130 (see all company filings)

EIN.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances